Uppsala, Sweden, May 12, 2010 / b3c newswire / – Biotage (STO: BIOT), a leading supplier of tools and technology for medicinal and analytical chemistry, announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen’s previous research in developing novel chemistries for and applications of solid-phase peptide synthesis.
Global demand from research scientists for synthetic peptides continues to grow at a double digit rate. Their needs are for increasingly longer and more complex peptides to study protein interactions, produce peptide antibodies, and understand complex disease states. As the number and complexity of peptides increase, the scientists and researchers need new tools that offer higher productivity and increased performance.
Biotage recently entered into collaboration with the German instrument company MultiSynTech GmbH (privately owned by Dr. Udo Treffer) and Professor Jensen to develop the Biotage Syro Wave automated peptide synthesizer introduced earlier this year. The instrument combines the proven technologies behind Biotage’s Initiator microwave instrument with the well-established Syro line of robotic peptide synthesizers from MultiSynTech.
Professor Jensen says “The Syro Wave is the first valve-free peptide synthesizer with integrated microwave heating. It holds great promise for the synthesis of both long peptides and even small proteins.”
For more information on the Biotage Syro Wave, please email This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.biotage.com
About Biotage - www.biotage.com
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 253 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.
For further product information contact:
Amit Mehrotra
Global Marketing Manager
Kungsgatan 76
SE-753 18 Uppsala
Sweden
Tel: +46 18 56 59 00
This email address is being protected from spambots. You need JavaScript enabled to view it.
For press information contact:
Rob Thompson
Director of Marketing Communications
10430 Harris Oaks Blvd. Suite C
Charlotte, North Carolina
USA
Tel: +1 704 654 4847
Fax: +1 704 654 4917
This email address is being protected from spambots. You need JavaScript enabled to view it.